Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation

Journal of Neuroscience

Volumn 16, Issue 9, 1996, Pages 3104-3111

  Hess, Ellen J ^a   Collins, Katherine A ^b   Wilson, Michael C ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

ADHD; amphetamine; coloboma; hyperactivity; locomotor activity; methylphenidate; mouse mutant; psychostimulant; SNAP 25; transgenic

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; NERVE PROTEIN; NEUROTRANSMITTER;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DELETION MUTANT; GENE; GENE EXPRESSION; HYPERKINESIA; IN SITU HYBRIDIZATION; LOCOMOTION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEREOTYPY; TRANSGENE; TRANSGENIC MOUSE;

EID: 0029947330     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-09-03104.1996     Document Type: Article

References (39)

1. Anastopoulos AD, Barkley RA (1988) Biological factors in attention deficit-hyperactivity disorder. Behav Ther 11:47-53.
2. Arnold LE, Christopher J, Huestis R, Smeltzer DJ (1978) Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction. Arch Gen Psychiatry 35:463-473.
3. Bark IC (1993) Structure of the chicken gene for SNAP-25 reveals duplicated exons encoding distinct isoforms of the protein. J Mol Biol 233:67-76.
4. Bark IC, Wilson MC (1994) Regulated vesicular fusion in neurons: snapping together the details. Proc Natl Acad Sci USA 91:4621-4624.
5. Bark IC, Hahn KM, Ryabinin AE, Wilson MC (1995) Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development. Proc Natl Acad Sci USA 92:1510-1514.
6. Barkley RA (1977) A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry 18:137-165.
7. Bell GL Pictete RL, Rutter WJ, Cordell B, Tischer E, Goodman HM (1980) Sequence of the human insulin gene. Nature 284:26-32.
8. Blasi J, Chapman ER, Link E, Binz T, Yamasaki S, De Camilli P, Sudhof TC, Niemann H, Jahn R (1993) Botulinum neurotoxin A selectively cleaves the presynaptic protein SNAP-25. Nature 365:160-163.
9. Butcher SP, Leptrot J, Aburthnott GW (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 122:245-248.
10. Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419-436.
11. Elia J, Borcherdung BG, Rapoport JL, Keysor CS (1991) Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36:141-155.
12. Florin SM, Kuczenski R, Segal DS (1995) Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations. J Pharmacol Exp Ther 274:231-241.
13. Geyer MA, Paulus MP (1992) Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats. NIDA Res Monogr 124:203-235.
14. Glick SD, Milloy S (1973) Rate-dependent effects of d-amphetamine on locomotor activity in mice: possible relationship to paradoxical amphetamine sedation in minimal brain dysfunction. Eur J Pharmacol 24:266-268.
15. Hess EJ, Jinnah HA, Kozak CA, Wilson MC (1992) Spontaneous locomotor hyperactivity in a mouse mutant with a deletion including the Snap gene on chromosome 2. J Neurosci 12:2865-2874.
16. Hess EJ, Collins KA, Copeland NG, Jenkins NA, Wilson MC (1994) Deletion map of the coloboma (Cm) locus on mouse chromosome 2. Genomics 21:257-261.
17. Hogan B, Beddington R, Constantini F, Lacy E (1986) In manipulating the mouse embryo: a laboratory manual, pp 217-252. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
18. Horikawa HPM, Saisu H, Ishizuka T, Sekine Y, Tsugita A, Odani S, Abe T (1993) A complex of rab3A, SNAP-25, VAMP/synaptobrevin-2 and syntaxins in brain presynaptic terminals. FEBS Lett 330:236-240.
19. MacGregor GR, Caskey CT (1989) Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res 17:2365.
20. McMillen BA (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol 10:429-432.
21. 2+ channel complex. FEBS Lett 326:255-260.
22. Oyler GA, Higgins GA, Hart RA, Battenberg E, Billingsley M, Bloom FE, Wilson MC (1989) The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J Cell Biol 109:3039-3052.
23. Pauls DL, Hurst CR, Kruger SD, Leckman JF, Kidd KK, Cohen DJ (1986) Gilles del la Tourette syndrome and attention deficit disorder with hyperactivity: evidence against a genetic relationship. Arch Gen Psychiatry 43:1177-1179.
24. Ryabinin AE, Sato TN, Morris PJ, Latchman DS, Wilson MC (1996) Immediate upstream promoter regions required for neurospecific expression of SNAP-25. J Mol Neurosci, in press.
25. Safer DJ, Krager JM (1988) A survey of medication treatment for hyperactive/inattentive students. JAMA 260:2256-2258.
26. Sahakian BJ, Robbins TW (1977) Are the effects of psychomotor stimulant drugs on hyperactive children really paradoxical? Med Hypother 3:154-158.
27. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
28. Scheel-Kruger J (1971) Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. Eur J Pharmacol 14:47-59.
29. Schiavo G, Rossetto O, Catsicas S, Poliverino de Laurento P, DasGupta BR, Benifenati F, Montecucco C (1993) Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E. J Biol Chem 268:23784-23787.
30. Searle AG (1966) New mutants. II. Coloboma. Mouse News Lett 35:27.
31. Shaywitz SE, Shaywitz BA (1984) Diagnosis and management of attention deficit disorder a pediatric perspective. Ped Clin N Amer 31:429-457.
32. Söllner T, Bennett T, Whiteheart SW, Scheller RH, Rothman JE (1993a) A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation and fusion. Cell 75:409-418.
33. Söllner T, Whiteheart SW, Brunner M, Erdjument-Bromage H, Germanos S, Tempst P, Rothman JE (1993b) SNAP receptors implicated in vesicle targeting and fusion. Nature 362:318-324.
34. Sulzer D, Rayport S (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5:797-808.
35. Sulzer D, Maidment JT, Rayport S (1993) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527-535.
36. Sulzer D, Chen R-K, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
37. Theiler K, Varnum DS (1981) Development of coloboma (Cm/+), a mutation with anterior lens adhesion. Anat Embryol 161:121-126.
38. Whalen CK, Henker B (1976) Psychostimulants and children: a review and analysis. Psychol Bull 83:1113-1130.
39. Wilson MC, Higgins GA (1989) In situ hybridization. In: Neuromethods: molecular neurobiological techniques. Vol 16 (Boulton AA, Baker GB, Campagnoni AT, eds). pp 239-284. Clifton. NJ: Humana.